GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intravenous Infusions Ltd (XGHA:IIL) » Definitions » General and Admin. Expense

Intravenous Infusions (XGHA:IIL) General and Admin. Expense : GHS Mil (TTM As of . 20)


View and export this data going back to 2015. Start your Free Trial

What is Intravenous Infusions General and Admin. Expense?

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Intravenous Infusions's General and Admin. Expense for the six months ended in . 20 was GHS0.00 Mil. Intravenous Infusions does not have enough years/quarters to calculate the General and Admin. Expense for the trailing twelve months (TTM) ended in . 20.


Intravenous Infusions General and Admin. Expense Historical Data

The historical data trend for Intravenous Infusions's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intravenous Infusions General and Admin. Expense Chart

Intravenous Infusions Annual Data
Trend
General and Admin. Expense

Intravenous Infusions Semi-Annual Data
General and Admin. Expense

Intravenous Infusions General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.


Intravenous Infusions General and Admin. Expense Related Terms

Thank you for viewing the detailed overview of Intravenous Infusions's General and Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Intravenous Infusions (XGHA:IIL) Business Description

Traded in Other Exchanges
N/A
Address
Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.

Intravenous Infusions (XGHA:IIL) Headlines